Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. GALAFOLD (migalastat)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

GALAFOLD (migalastat)

Medicine - Posted on Dec 18 2023
Active substance (DCI)
  • migalastat
history (2)
  • 9/5/22

    GALAFOLD (chlorhydrate de migalastat) - Déficit en a-galactosidase A

    Le laboratoire a informé la HAS de sa demande de non remboursement dans l’indication « Traitement à long terme des adolescen...
    icône flèche
  • 11/9/16

    GALAFOLD (migalastat), chaperone molecule for amenable α-galactosidase mutations

    Minor improvement in the treatment of Fabry disease, in patients with an amenable mutation . GALAFOLD has Marketing Authoris...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • Demande en cours
Manufacturer
AMICUS THERAPEUTICS SAS
Presentation

GALAFOLD 123 mg, gélules (code CIS : 62876801) 
plaquette(s) thermoformée(s) PVC polychlortrifluoroéthylène PVC-Aluminium de 14 gélule(s) (CIP : 34009 300 608 2 7)

All our publications
    Congenital, genetic and rare diseases Drug therapy Metabolic diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
WYWJEegdZra3HBt6